Cynosure (CYNO) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts CYNO Hot Sheet
Price: $66.00 --0%
Financial Fact:
Cost of revenues: 43.58M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of revenues: 43.58M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cynosure (NASDAQ: CYNO) reported Q4 EPS of $0.42, $0.04 better than the analyst estimate of $0.38. Revenue for the quarter came in at $102.4 million versus the consensus estimate of $96.54 million.
For earnings history and earnings-related data on Cynosure (CYNO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
